New Step by Step Map For Imipenem
MI-CP151 was a stage 1b randomised, double-blind, placebo managed, dose-escalation, multicentre analyze To judge various intravenous doses of sifalimumab, in adult patients with dermatomyositis or polymyositis (NCT00533091). Most important demo objectives ended up to evaluate the security and tolerability of sifalimumab in dermatomyositis or polymy